Innovation
4 patent families — focus: Human necessities; filing pace accelerating. Cited 780 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
Social engagement
Social engagement: 4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include The Column Group, Atlas Venture, Droia Ventures, Digitalis Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Angel & family office | 1 | 17% |
| Other / undisclosed | 1 | 17% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
9 Jun 2026 · Senior Scientist, CMC & External Manufacturing
Based on job postings tracked across public sources.
Recent activity
4 Jun 2026
Event
BioCentury Inc. Grand Rounds
14 May 2026
Event
TIDES USA Oligonucleotide and Peptide Therapeutics conference
9 Apr 2026
Recognition